Physician profile
Derek Kram
NPI 1184616708
$3,575.15
in general payments reported to CMS, 2019-2025
26 companies · $754 in 2025
The $754 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $652 · 2020: $363 · 2021: $830 · 2022: $482 · 2023: $268 · 2024: $226 · 2025: $754.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,247.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,373.95 | 2019-2025 | Hoffmann, Gamma, Triathlon |
| Arthrex, INC. | $251.73 | 2021-2023 | Distal Extremities Implants Foot & Ankle Ttc Nail |
| Supreme Orthopedic Systems, LLC | $222.09 | 2022-2025 | |
| Depuy Synthes Sales INC. | $182.89 | 2019-2021 | |
| Globus Medical, INC. | $150.00 | 2021 | |
| Si-Bone, INC. | $144.92 | 2021 | |
| Ferring Pharmaceuticals INC. | $141.66 | 2019-2022 | |
| Biocomposites INC | $132.27 | 2025 | Stimulan |
| Biotissue Holdings INC. | $124.69 | 2022 | |
| Innovation Technologies INC | $110.08 | 2023 | Irrisept |
| Bioventus LLC | $93.91 | 2019-2024 | Durolane |
| Amgen INC. | $91.49 | 2019-2025 | Evenity, Prolia, Krystexxa |
| Smith+Nephew, INC. | $84.75 | 2019-2025 | Pico 7, Pico 14 |
| Pacira Pharmaceuticals Incorporated | $68.48 | 2024-2025 | Exparel, Zilretta, Iovera |
| Medtronic USA, INC. | $68.27 | 2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $58.22 | 2020-2021 | |
| Tactile Systems Technology INC | $57.14 | 2019 | |
| Zimvie INC. | $41.63 | 2022 | |
| Medtronic, INC. | $33.59 | 2021 | |
| Fidia Pharma USA INC. | $32.83 | 2019-2024 | Hymovis |
| 4web, INC. | $29.18 | 2021 | |
| Misonix INC | $25.40 | 2021 | |
| Horizon Therapeutics Plc | $17.92 | 2021 | |
| Clarus Therapeutics INC. | $13.64 | 2021 | |
| Ermi LLC | $13.38 | 2019 | |
| Acell, INC. | $11.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Kram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.